Co-Diagnostics Inc (NASDAQ: CODX) on Friday, soared 10.85% from the previous trading day, before settling in for the closing price of $0.27. Within the past 52 weeks, CODX’s price has moved between $0.23 and $2.23.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company slipped by -27.40% over the past five years. The company achieved an average annual earnings per share of 45.56%. With a float of $30.68 million, this company’s outstanding shares have now reached $36.18 million.
Let’s look at the performance matrix of the company that is accounted for 132 employees. In terms of profitability, gross margin is -12.25%, operating margin of -4079.44%, and the pretax margin is -3574.77%.
Co-Diagnostics Inc (CODX) Insider Updates
Observing investor behavior towards Medical Devices industry stocks is more important than anything else. The insider ownership of Co-Diagnostics Inc is 9.00%, while institutional ownership is 15.41%.
Co-Diagnostics Inc (CODX) Performance Highlights and Predictions
As on 9/30/2024, Multinational firm has announced its last quarter scores, in which it reported -0.33 earnings per share (EPS) for the period topping the consensus outlook (set at -0.33) by 0. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.09 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 45.56% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 37.69% during the next five years compared to -27.40% drop over the previous five years of trading.
Co-Diagnostics Inc (NASDAQ: CODX) Trading Performance Indicators
Co-Diagnostics Inc (CODX) is currently performing well based on its current performance indicators. A quick ratio of 3.83 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 19.88.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.12, a number that is poised to hit -0.14 in the next quarter and is forecasted to reach -0.42 in one year’s time.
Technical Analysis of Co-Diagnostics Inc (CODX)
Co-Diagnostics Inc (NASDAQ: CODX) saw its 5-day average volume 17.4 million, a positive change from its year-to-date volume of 1.01 million. As of the previous 9 days, the stock’s Stochastic %D was 64.14%.
During the past 100 days, Co-Diagnostics Inc’s (CODX) raw stochastic average was set at 24.48%, which indicates a significant decrease from 40.83% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0233 in the past 14 days, which was lower than the 0.0366 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.2715, while its 200-day Moving Average is $0.5489. Nevertheless, the first resistance level for the watch stands at $0.3595 in the near term. At $0.4247, the stock is likely to face the second major resistance level. The third major resistance level sits at $0.4695. If the price goes on to break the first support level at $0.2495, it is likely to go to the next support level at $0.2047. Assuming the price breaks the second support level, the third support level stands at $0.1395.
Co-Diagnostics Inc (NASDAQ: CODX) Key Stats
Market capitalization of the company is 11.33 million based on 33,573K outstanding shares. Right now, sales total 3,920 K and income totals -37,640 K. The company made 50 K in profit during its latest quarter, and -7,530 K in sales during its previous quarter.
